2014
DOI: 10.4161/gmcr.29193
|View full text |Cite
|
Sign up to set email alerts
|

Risk, regulation, and biotechnology: The case of GM crops

Abstract: The global regulation of products of biotechnology is increasingly divided. Regulatory decisions for genetically modified (GM) crops in North America are predictable and efficient, with numerous countries in Latin and South America, Australia and Asia following this lead. While it might have been possible to argue that Europe's regulations were at one time based on real concerns about minimizing risks and ensuring health and safety, it is increasingly apparent that the entire European Union (EU) regulatory sys… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 17 publications
0
3
0
Order By: Relevance
“…The EU precautionary approach and its unique application to the defined process of genetic modification is often reflected in emerging regulatory networks elsewhere in the world where new biosafety laws are being adopted and implemented (Bayer et al ., ; Gupta et al ., ; Okeno et al ., ). Elsewhere, countries such Australia, Argentina and Brazil have successfully adopted process‐based regulatory approaches that may factor social and economic factors into a regulatory framework, but which achieve regulatory approvals in a manner relatively consistent with that seen in North America (Smyth and Phillips, ).…”
Section: Regulatory Backgroundmentioning
confidence: 99%
“…The EU precautionary approach and its unique application to the defined process of genetic modification is often reflected in emerging regulatory networks elsewhere in the world where new biosafety laws are being adopted and implemented (Bayer et al ., ; Gupta et al ., ; Okeno et al ., ). Elsewhere, countries such Australia, Argentina and Brazil have successfully adopted process‐based regulatory approaches that may factor social and economic factors into a regulatory framework, but which achieve regulatory approvals in a manner relatively consistent with that seen in North America (Smyth and Phillips, ).…”
Section: Regulatory Backgroundmentioning
confidence: 99%
“…Given the fear of the unknown, this may create an apprehension in the layperson's mind that such a plant may not be safe to consume or may pose an ecological hazard. As such, GMO skeptics would have confusedly managed to promote the assumption that a genetically-unmodifiedorganism (GUMO), e.g., the 'Organic' gimmick, would be considered safer and more acceptable to the victimised consumer, because natural [44]. The question is: Is the average consumer aware that conventionally bred crops are also GMOs?…”
Section: Discussionmentioning
confidence: 99%
“…Thus, the persistent counterproductive arguments insisted upon by anti-GMO/biotechnology activists become generally meaningless, unsubstantiated and should, therefore, be dismissed [48]. Furthermore, the controversial health and environmental hazards, claimed to be linked to plant biotechnology in general, should best be left to be substantiated by solid scientific evidence, as defined and prescribed by the Food and Agriculture Organization (FAO) [44], free from any political agendas, negative opinions or unproven theories.…”
Section: Discussionmentioning
confidence: 99%